# Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)

> **NCT05236842** · PHASE2 · COMPLETED · sponsor: **Desitin Arzneimittel GmbH** · enrollment: 298 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Sulthiame

## Key facts

- **NCT ID:** NCT05236842
- **Lead sponsor:** Desitin Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-23
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-31
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236842, "Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05236842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*